Unmet Needs and Future Directions for Ovarian Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Unmet Needs and Future Directions for Ovarian Cancer | Targeted Onc…
Feb 11, 2022
targetedonc.com
Case Presentation: A 72-Year-Old Woman With Metastatic Colorectal Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Case Presentation: A 72-Year-Old Woman With Metastatic Colorecta…
Oct 4, 2021
targetedonc.com
Case Presentation: A 57-Year-Old Woman With Ovarian Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Case Presentation: A 57-Year-Old Woman With Ovarian Cancer | Tar…
Sep 23, 2021
targetedonc.com
The Role of Age in Bone Marrow and Stem Cell Transplants for MDS | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
The Role of Age in Bone Marrow and Stem Cell Transplants for MDS | T…
Jul 14, 2022
targetedonc.com
The Mechanism of Action of Olaparib | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
The Mechanism of Action of Olaparib | Targeted Oncology - Im…
Jul 30, 2013
targetedonc.com
Understanding JZP898: A Breakthrough mRNA Therapy for Solid Tumors | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Understanding JZP898: A Breakthrough mRNA Therapy for …
Aug 16, 2024
targetedonc.com
An Overview of Myelodysplastic Syndrome | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
An Overview of Myelodysplastic Syndrome | Targeted Oncology - I…
Sep 22, 2021
targetedonc.com
Case Review: Newly Diagnosed Stage IV Hodgkin Lymphoma | Tar…
Jan 10, 2019
targetedonc.com
Risk of Recurrence in Stage 3B CRC | Targeted Oncology - Immunother…
Oct 7, 2016
targetedonc.com
Monitoring Mantle Cell Lymphoma: PET Scans and MRD | Targeted O…
Sep 13, 2017
targetedonc.com
Choosing Between Atezolizumab and Pembrolizumab in Lung Canc…
Jul 2, 2018
targetedonc.com
Trimodality Therapy Plus Atezolizumab Investigated for Bla…
May 5, 2022
targetedonc.com
A 52-Year-Old Woman With HER2-Positive Breast Cancer | Targeted …
May 22, 2019
targetedonc.com
The Targeted Pulse: NK-Cell Therapies, T-DXd and Adagrasib i…
Apr 7, 2024
targetedonc.com
Mechanism of Action: Abraxane | Targeted Oncology - Immunothera…
Feb 5, 2014
targetedonc.com
Current Treatment Options for DLBCL Besides R-CHOP Chemoth…
Mar 16, 2020
targetedonc.com
AML: Toxicities With CPX-351 | Targeted Oncology - Immunothera…
Jul 9, 2018
targetedonc.com
Targeting PIK3CA Mutations in Breast Cancer | Targeted Oncolog…
Aug 12, 2023
targetedonc.com
NCCN Guidelines for Castleman's Disease | Targeted Oncology - Im…
Oct 31, 2016
targetedonc.com
Multiple Myeloma Treatment: New Therapies vs Stem Cell Transplan…
Apr 3, 2024
targetedonc.com
Case Overview: A 75-Year-Old Man with Multiple Myeloma | Targeted …
Apr 7, 2021
targetedonc.com
Belumosudil Shows Sustained Efficacy and Safety for Chronic G…
Mar 11, 2024
targetedonc.com
Platinum Sensitivity vs Resistance and Treatment Selection in Ovaria…
Apr 27, 2021
targetedonc.com
Choosing Second-Line Therapy for HCC After Atezolizumab/Bevacizu…
Sep 6, 2022
targetedonc.com
The Differences Between mCRPC and nmCRPC | Targeted Oncolog…
Jul 17, 2019
targetedonc.com
Mismatch Repair Defects and Endometrial Carcinoma | Targete…
Jan 28, 2022
targetedonc.com
FDA's July 2024 Roundup: Breakthroughs and Milestones in …
Aug 2, 2024
targetedonc.com
Steroid-Refractory Acute Graft-Versus-Host Disease Defined | Tar…
Mar 22, 2021
targetedonc.com
Case Presentation: 63-Year-Old Man With Advanced HCC | Targeted On…
Sep 9, 2019
targetedonc.com
When to Choose Chemotherapy vs CDK4/6 Inhibitors | Targeted Onco…
Apr 29, 2019
targetedonc.com
See more videos
Static thumbnail place holder